ReACH/IIMS Announce 2019-2020 Population Health Pilot Grants Program

The ReACH Center, in conjunction with the Institute for Integration of Medicine and Science (IIMS) have announced the 2019-2020 ReACH/IIMS Population Health Pilot Grants Program.  Applications are due January 13, 2020 by 5:00 pm.  To learn more about this RFA please visit our ReACH/IIMS Popultion Health Pilot Grants page! 

ReACH is Seeking a Research Area Specialist!

The ReACH Center is recruiting for a Research Area Specialist-Associate position.  For more information about this opening, please visit our Staff Opportunites page.  

Become a Member of the ReACH Center

Do you have an interest in the health of San Antonio and the South Texas region?  Become a member of the ReACH Cenrer!  Membership is free provides the opportunity to get involved with shaping the future of population health, clinical and translational research in South Texas!  For more information and to sign up click here!

Contact Us

7411 John Smith Road

Suite 1050

San Antonio, TX



Tel: 210-562-5551

Fax: 210-562-5560

Alarming new CDC numbers on viral hepatitis in the United States

Last month, the Centers for Disease Control and Prevention (CDC) released new surveillance data on viral hepatitis in the United States. 

The numbers paint a grim picture.

  • From 2010 to 2016, reported cases of acute hepatitis C (HCV) increased 3.5-fold.
  • Between 2015 and 2016, the number of reported cases of HCV increased 21.8 percent.
  • In 2016, an estimated 41,200 new HCV infections were reported.
  • In 2016, American Indians/Alaska Natives had the highest HCV-related mortality rate compared with other racial/ethnic populations, and persons aged 55–64 years had the highest HCV-related mortality rate compared with other age groups.

These data confirm that high rates of injection drug use, lack of sterile equipment, and the unavailability of testing and treatment for lower-income and incarcerated people contribute to the epidemic of viral hepatitis.  

The ReACH Center has several ongoing programs that strive to Screen, Treat, or Prevent (STOP) liver cancer and failure in Texans through one-time baby boomer screening for HCV, education and community collaboration, practice transformation in medically underserved areas with a lack of access to specialist care and policy advocacy.  To learn more about our STOP HCC-HCV program please visit